Amendment to OncoCyte Corporation 2018 Equity Incentive Plan (July 24, 2021)

Summary

This amendment updates the OncoCyte Corporation 2018 Equity Incentive Plan by increasing the total number of shares of common stock available for awards to 21,000,000. It specifies how shares are counted against this limit depending on the type of award granted. The company is required to keep enough shares available to fulfill these awards. The amendment was approved by shareholders on July 24, 2021.

EX-10.1 2 ex10-1.htm

Exhibit 10.1

AMENDMENT TO

ONCOCYTE CORPORATION

2018 EQUITY INCENTIVE PLAN

Approved by Shareholders July 24, 2021

Section 4.1 of the OncoCyte Corporation 2018 Equity Incentive Plan is amended to read as follows:

4.1 Subject to adjustment in accordance with Section 11, a total of 21,000,000 shares of Common Stock shall be available for the grant of Awards under the Plan. Any shares of Common Stock granted in connection with Options and Stock Appreciation Rights shall be counted against this limit as one share for every one Option or Stock Appreciation Right awarded. Any shares of Common Stock granted in connection with Awards other than Options and Stock Appreciation Rights shall be counted against this limit as two (2) shares of Common Stock for every one (1) share of Common Stock granted in connection with such Award. During the terms of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards.